Our perspectives in one place

News

See all
Statement 1 Feb 2023

EB152 statement on substandard and falsified medical products

On 1 February 2023, IPSF submitted a statement delivered on behalf of IPSF, IAPO, and IFPMA for the EB152 agenda item related to substandard and falsified medical products.

Read more
Statement 31 Jan 2023

Strengthening the global architecture for health emergency preparedness, response, and resilience

IFPMA delivered a constituency statement for the agenda item related to strengthening the global architecture for health emergency preparedness, response, and resilience at the 152nd session of the Executive Board at the World Health Organization in Geneva.

Read more
Press release 17 Jan 2023

IFPMA announces new head of communications

Read more
Statement 12 Jan 2023

Statement to the IHR Review Committee on amendments to the International Health Regulations

IFPMA encourages the consistent coordination of the INB and IHR processes to ensure a non-duplicative, fit-for-purpose outcome for all.

Read more
Statement 21 Dec 2022

Statement on WTO decision to extend the deadline to consider a waiver of intellectual property rights on COVID-19 therapeutics and diagnostics

IFPMA expresses its disappointment at the decision to consider an extension of a waiver of intellectual property rights on COVID-19 therapeutics and diagnostics taken by Member States at the World Trade Organization (WTO).

Read more
Press release 20 Dec 2022

Multilateral framework to nurturing future biodiversity welcomed, despite no acknowledgement yet of the importance for global health security to exempt pathogens

We welcome the adoption at the 15th meeting of the Conference of the Parties to the UN Convention on Biological Diversity (COP15) of a framework that addresses biodiversity loss across the globe.

Read more

Join our media mailing list

If you're a journalist, please join our mailing list to receive regular press notifications.

    Top